Antihypertensive drug adherence in 83,884 Chinese patients: A population-based cohort study

significantly from 7,4±1,5 to 7,2±1,4 mg/dl (p ns). MAU was reduced significantly from 27,6% subjects to 11,8% (0,05) and also the proteinuria was reduced from 13,1% patients to 4% (0,05). The percentage of hypertensiveswith altered creatinine clearancewas reduced from18,5% to 10,5%, but insignificantly. Conclusions: Treatment with candesartan in hypertensive patients, especially in diabetics, reduces BP, offers a favorable metabolic profile and protects the kidney.